ADUS Form 4: Director Veronica Hill-Milbourne Sells 1,571 Shares
Form 4: Veronica Hill-Milbourne, a director of Addus HomeCare Corp. (ADUS), sold 1,571 shares of common stock on 08/19/2025 at a reported price of $114.93 per share, reducing her direct beneficial ownership to 5,067 shares.
Rhea-AI Filing Summary
Form 4: Veronica Hill-Milbourne, a director of Addus HomeCare Corp. (ADUS), sold 1,571 shares of common stock on 08/19/2025 at a reported price of $114.93 per share, reducing her direct beneficial ownership to 5,067 shares. The filing was signed by an attorney-in-fact on 08/21/2025. This report discloses an insider sale and the remaining direct ownership stake held by the reporting person.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine director sale; size modest relative to typical outstanding shares, no new compensation or option exercise disclosed.
The Form 4 shows a straightforward open-market sale of 1,571 shares at $114.93, leaving 5,067 shares held directly. There are no derivative transactions or new grants reported. For market impact, the disclosed sale is a routine insider liquidity event and, by itself, does not indicate a change in corporate strategy or firm fundamentals.
TL;DR: Insider sale by a director appears ordinary and fully reported; documentation includes attorney-in-fact signature.
The filing accurately identifies the reporting person as a director and uses the correct transaction code (S for sale). The signature by an attorney-in-fact on 08/21/2025 is provided, satisfying Form 4 execution requirements. No indications of unusual governance events, such as accelerated sales tied to departure or related-party transactions, are present in the document.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,571 | $114.93 | $181K |
FAQ
What did ADUS director Veronica Hill-Milbourne report on Form 4?
What type of transaction code is used in the filing?
When was the Form 4 signed and by whom?
Does the Form 4 report any option exercises or derivative transactions for ADUS?
AI-generated analysis. How Rhea-AI works. Not financial advice.